Supplementary Data Figure S1 from Somatic HLA Class I Loss Is a Widespread Mechanism of Immune Evasion Which Refines the Use of Tumor Mutational Burden as a Biomarker of Checkpoint Inhibitor Response
crossref(2023)
摘要
HLA-I germline zygosity has no impact on patient survival in ICI-treated NSCLC
查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要